Alkem Laboratories looking at partnerships, in-licensing deals in US

19 Jul 2021 Evaluate

Alkem Laboratories is looking at partnerships and in-licensing deals in the US to bolster its presence in the world's largest market for pharmaceutical products. It also remains positive about its growth prospects in the domestic market with better access to healthcare facilities and increasing penetration of medical insurance expected to act as key growth driver. In the medium to long term, the company's investment in the areas of control substances from its US facilities and biosimilars through its subsidiary at Enzene will also help drive growth.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Alkem Laboratories Share Price

5409.65 -69.80 (-1.27%)
24-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1817.60
Dr. Reddys Lab 1351.25
Cipla 1475.90
Lupin 2168.30
Zydus Lifesciences 964.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.